Evidence map›Paper›PMID 24361772›Full record

ReviewReviews in the neurosciences2014

Cognitive control in alcohol use disorder: deficits and clinical relevance.

Claire E Wilcox, Charlene J Dekonenko, Andrew R Mayer, Michael P Bogenschutz, Jessica A Turner

Registry-linked trialAbstract readReview
In one paragraph

Review in Reviews in the neurosciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06793488 (Neural Mechanisms of Anxiety During Early and Protracted Abstinence in Alcohol Use Disorder), which is not on this map. Cited by 93 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06793488 early_phase1recruitingnot on this mapstarted 2025, after this paper: background citation

Neural Mechanisms of Anxiety During Early and Protracted Abstinence in Alcohol Use Disorder

TypeinterventionalSponsorColumbia UniversityRan2025 to 2029Enrolled60ConditionsAlcohol Use DisorderArmsDisulfiram 250 mg, functional MRI
3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claire E Wilcox
Charlene J Dekonenko
Andrew R Mayer
Michael P Bogenschutz
Jessica A Turner

Funding

Neural Mechanisms of Change During Alcohol Use DisorderTreatment with PrazosinK23AA021156 · NIAAA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WILCOX, CLAIRE · 2013 to 2017
$919k
NIAAA NIH HHS K23 AA021156NIAAA NIH HHS K23 AA021156-01A1
6 · The paper itself

Abstract

Cognitive control refers to the internal representation, maintenance, and updating of context information in the service of exerting control over thoughts and behavior. Deficits in cognitive control likely contribute to difficulty in maintaining abstinence in individuals with alcohol use disorders (AUD). In this article, we define three cognitive control processes in detail (response inhibition, distractor interference control, and working memory), review the tasks measuring performance in these areas, and summarize the brain networks involved in carrying out these processes. Next, we review evidence of deficits in these processes in AUD, including both metrics of task performance and functional neuroimaging. Finally, we explore the clinical relevance of these deficits by identifying predictors of clinical outcome and markers that appear to change (improve) with treatment. We observe that individuals with AUD experience deficits in some, but not all, metrics of cognitive control. Deficits in cognitive control may predict clinical outcome in AUD, but more work is necessary to replicate findings. It is likely that performance on tasks requiring cognitive control improves with abstinence, and with some psychosocial and medication treatments. Future work should clarify which aspects of cognitive control are most important to target during treatment of AUD.

Indexed as

AlcoholismBrainCognition DisordersExecutive FunctionHumansInhibition, PsychologicalMemory, Short-Term

Identifiers

PMID24361772
PMCPMC4199648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.